Name: UofT AI Conference
Start: 18/02/2022 01:30 PM +00:00
End: 20/02/2022 02:30 AM +00:00

Google&rsquo;s mission is to organize the world&rsquo;s information and make it universally accessible and useful. AI is helping us do that in exciting new ways, solving problems for our users, our customers, and the world.&nbsp;
AI is making it easier for people to do things every day, whether it&rsquo;s searching for photos of loved ones, breaking down language barriers in Google Translate, typing emails on the go, or getting things done with the Google Assistant. AI also provides new ways of looking at existing problems, from rethinking healthcare to advancing scientific discovery.

Google

At AltaML We are - Applying AI to Evevate Human potential
Humans and the technology we use are creating more data than ever before.
At AltaML, we believe that AI can unlock the knowledge in that data to&nbsp;
liberate and augment to focus on bigger issues and to help people make
better decisions in life and in business. Better decisions can help humans&nbsp;
prosper in ways yet to be deifned. With this pupose we are focused&nbsp; not on research,&nbsp;
but on the application of AI, to enable decisions today that impact our future and change the world for the better
<a title="AltaML Website" href="http://www.altaml.com">www.altaml.com</a>
&nbsp;

AltaML

In 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most-effective vaccines against the COVID-19 pandemic.
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years.&nbsp;

Moderna

At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you. We're here to help every creator turn their "what if" into what is. Let's create something that will change everything.

Deep Genomics is a Toronto-based startup company that is changing the future of medicine using artificial intelligence. Founded in 2015, Deep Genomics brings together a multidisciplinary team of world-leading experts in machine learning, genomics, chemistry and biology. Together we are on a mission to develop an AI-powered platform for rapid discovery and development of the best genetic medicines.
Our AI Workbench enables us to efficiently find drug candidates with desirable properties. We are focusing on the development and marketing of steric blocking oligonucleotides (SBOs) that target the genetic determinants of disease at the level of RNA or DNA. These genetic diseases are mediated by altered molecular phenotypes, such as transcription, splicing, translation and protein binding. Predicting those alterations is our core competency. The oligonucleotide therapeutic design space includes tens of billions of compounds, but our platform makes it possible to search this space efficiently.
Our platform incorporates the most advanced biological and medical knowledge, is driven by the most powerful automation technologies, and is built using proprietary as well as public datasets. Our work has appeared in Science, Nature, Nature Genetics, Nature Medicine, Nature Methods, Proceedings of the IEEE, NIPS, Bioinformatics, RECOMB and ISMB.&nbsp;

Deep Genomics

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services&mdash;all powered by the world&rsquo;s largest network of Advanced Technology and Intelligent Operations centers. Our people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.&nbsp;

Accenture

In 1999 sparked the growth of the PC gaming market, redefined modern computer graphics, and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI &mdash; the next era of computing &mdash; with the GPU acting as the brain of computers, robots, and self-driving cars that can perceive and understand the world.
Unfortunately the NVIDIA representatives were not available to speak with you directly. Click <a href="https://docs.google.com/forms/d/e/1FAIpQLScceK5l3dXP4TDF7Q4obYHB9CmZIelqZzQE6c2ZdBrxP-vwfA/viewform">here</a> to let them know you are want to talk to their representatives and learn more about their opportunities.

Nvidia

We&rsquo;ve always been fascinated by human intelligence &ndash; it shaped the modern world we live in today.&nbsp;
Intelligence allows us to learn, imagine, cooperate, create, communicate, and so much more. By better understanding different aspects of intelligence, we can use this knowledge as inspiration to build novel computer systems that learn to find solutions to difficult problems on their own.&nbsp;

DeepMind

23andMe is a leading consumer genetics and research company. Founded in 2006, our mission is to help people access, understand, and benefit from the human genome.

23andMe

The Vector Institute is an independent, not-for-profit corporation dedicated to research in the field of artificial intelligence (AI), excelling in machine and deep learning. Check out some of our Faculty Members and their leading research, who will be speaking throughout the conference.
Opportunities for Students:
<ul>
<li>Applications now open for Research Internships!<a href="vectorinstitute.ai/internships"> vectorinstitute.ai/internships</a></li>
<li>Starting an AI master's degree in Ontario this upcoming year? Explore the Vector Scholarship in Artificial Intelligence <a href="vectorinstitute.ai/scholarship">vectorinstitute.ai/scholarship</a></li>
<li>We are hiring for full-time roles in AI! <a href="vectorinstitute.ai/opportunities">vectorinstitute.ai/opportunities</a></li>
</ul>

Vector Institute

Use this time to engage with your peers and win some more engagement points. Winners will be announced at the end of the day!&nbsp;

Check-in Hour + Networking

Pedro O. Pinheiro

Albi Celaj

Lunch + Networking

Rick Makos

Parisa Rashidi, Ph.D., is an associate professor in the J. Crayton Pruitt Family Department of Biomedical Engineering. Dr. Rashidi&rsquo;s research aims to develop intelligent patient monitoring systems using artificial intelligence and sensing technology. Her lab is working towards predicting acuity state of patients in real-time.

Parisa Rashidi

Augmented Intelligence in Critical Care

ProjectX Winner Talks

Frank Rudzicz

Say 'ah': Speech and language in medicine

Computational creativity in an emergent field in artificial intelligence, centering on fundamental questions such as: What is creativity? Can computers be creative? Instead of using the computer as a tool, can it be an equal collaborator, or even an independent artist? This talk will discuss goals of computational creativity as well as present notable systems at the intersection of computing with visual art and music

Maya Ackerman

Creative Machines

As a conclusion, we'll have some quick closing remarks and declare the winner of the prizes for engagement points!

Agenda

Speakers.css-1f6omqm{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#5d5d5d;font-family:'Poppins',sans-serif;margin-left:0.8rem;}29 Speakers

Varun Lodaya

Eugene Wen

Yale Song

Parisa Rashidi

Frank Rudzicz

Animesh Garg

Max & Tegmark

Maya Ackerman

Tomi Poutaten

Rama K Akkiraju

Nicolas Papernot

Diana Inkpen

Alan Aspuru-Guzik

Stephen Zheng

Adrianna Loback

Geoffrey Hinton

Albi Celaj

Pedro O. Pinheiro

Johannah Thumb

Stella Aslibekyan

Farhad Hormozdiari

Shaikh Quader

Naomi Carmichael

Rick Makos

Shreshth Gandhi

Chris Jenkins

Manav Shah